Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Tweet
Share
E-mailGet Alerts CLDI Hot Sheet
Join SI Premium – FREE
Calidi Biotherapeutics (NYSE: CLDI) reported Q2 EPS of ($2.94).
For earnings history and earnings-related data on Calidi Biotherapeutics (CLDI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- RCM Technologies (RCMT) Tops Q2 EPS by 17c
- Nuscale Power (SMR) PT Lowered to $15 at B.Riley
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
